clopidogrel and Hematologic Diseases

clopidogrel has been researched along with Hematologic Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Budziaszek, Ł; Czaniecka, M; Gajos, G; Kleczkoska, A; Podolec, J; Zmudka', K1
Steinhubl, SR; Topol, EJ1
Marks, KR; McCullough, PA1

Reviews

3 review(s) available for clopidogrel and Hematologic Diseases

ArticleYear
[New approach to interventional cardiology treatment with personalized medicine].
    Przeglad lekarski, 2008, Volume: 65, Issue:12

    Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clopidogrel; Drug Resistance; Hematologic Diseases; Humans; Myocardial Infarction; Personal Health Services; Ticlopidine; Treatment Failure

2008
Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
    Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Hematologic Diseases; Humans; Platelet Aggregation Inhibitors; Premedication; Randomized Controlled Trials as Topic; Stents; Ticlopidine

1999
Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.
    Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3

    Topics: Anemia, Aplastic; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Health Policy; Hematologic Diseases; Hemorrhage; Humans; Multivariate Analysis; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Premedication; Purpura, Thrombotic Thrombocytopenic; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Stents; Ticlopidine; Treatment Outcome

1999